Delivery Order SPE2D018D0006-SPE2D325F2269
Award Date
11/22/24
Potential Completion Date
11/27/24
Potential Value
$5.1K
Federal Agency
Medical Supply Chain
Awardee
Eagle Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westwood, NJ 07677, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Ryanodex (250mg vials). The contract has a firm fixed price of $92,838.80 and a period of performance through April 6, 2023. This award is part of Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which has a...
This federal contract award to Eagle Pharmaceuticals, Inc. (doing business as Eagle Pharmaceuticals) is a delivery order worth $10,161.24 for the supply of the drug Ryanodex (250mg vial). The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is responsible for procuring medical supplies to support Department of Defense healthcare operations. The contract has a firm fixed-price structure and a completion date of May 10, 2024. Eagle Pharmaceuticals, as the prime...
This is a federal contract award to Eagle Pharmaceuticals, Inc., a specialized pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Ryanodex, a 250mg injectable medication used for the treatment and prevention of malignant hyperthermia in high-risk patients. The contract award, with a ceiling value of $10,161.24, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 29, 2024. This award is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $170,847.06, is for the delivery of other medical supplies, specifically the 250mg injectable drug Ryanodex used to treat and prevent malignant hyperthermia. The delivery order has a firm fixed-price pricing type and an ultimate completion date of April 7, 2025. This contract is not set aside and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex, a 250mg injectable medication used for the treatment and prevention of malignant hyperthermia. The contract has a ceiling value of $10,161.24 and is a firm fixed price delivery order that runs through August 2024. Eagle Pharmaceuticals is a specialized pharmaceutical company that provides critical medications to the U.S. federal...
This federal contract award SPE2D018D0006|SPE2D325F7998, valued at $15,877.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc. The contract is for the delivery of 4567758875 - RYANODEX 250 MG VIAL, a critical pharmaceutical product used to treat and prevent malignant hyperthermia in high-risk patients. The contract is a firm fixed-price delivery order with a completion date of March 18, 2025. Eagle Pharmaceuticals, a...
This federal contract award, valued at $6,421.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a performance period ending on March 19, 2025. The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $4,816.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a specific medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 21, 2025. The contract award is not designated with a set-aside requirement, indicating an...
Defense Logistics Agency, an agency of the Department of Defense, awarded a $2,858.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250 mg vials of Ryanodex. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply pharmaceutical products and services to DLA. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with an end date of October 11, 2023....
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $9,632.64, is for the supply of RYANODEX 250 MG VIALS. The contract has an ultimate completion date of April 21, 2025 and a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...